| IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma S Ma, Q Cheng, Y Cai, H Gong, Y Wu, X Yu, L Shi, D Wu, C Dong, H Liu Cancer research 74 (7), 1969-1982, 2014 | 285 | 2014 |
| The mechanism of anti–PD-L1 antibody efficacy against PD-L1–negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector W Dong, X Wu, S Ma, Y Wang, AP Nalin, Z Zhu, J Zhang, DM Benson, ... Cancer discovery 9 (10), 1422-1437, 2019 | 243 | 2019 |
| The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes G Liu, S Ma, S Li, R Cheng, F Meng, H Liu, Z Zhong Biomaterials 31 (29), 7575-7585, 2010 | 196 | 2010 |
| Galactose-Decorated Cross-Linked Biodegradable Poly(ethylene glycol)-b-poly(ε-caprolactone) Block Copolymer Micelles for Enhanced Hepatoma-Targeting … R Yang, F Meng, S Ma, F Huang, H Liu, Z Zhong Biomacromolecules 12 (8), 3047-3055, 2011 | 178 | 2011 |
| Endosomal pH-Activatable Poly(ethylene oxide)-graft-Doxorubicin Prodrugs: Synthesis, Drug Release, and Biodistribution in Tumor-Bearing Mice L Zhou, R Cheng, H Tao, S Ma, W Guo, F Meng, H Liu, Z Liu, Z Zhong Biomacromolecules 12 (5), 1460-1467, 2011 | 165 | 2011 |
| Reduction and temperature dual-responsive crosslinked polymersomes for targeted intracellular protein delivery R Cheng, F Meng, S Ma, H Xu, H Liu, X Jing, Z Zhong Journal of materials chemistry 21 (47), 19013-19020, 2011 | 156 | 2011 |
| The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity YJ Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS, Sun JC, Chen J, Caligiuri MA J Exp Med. 218 (8), e20210279., 2021 | 111 | 2021 |
| Targeting the RNA m6A modification for cancer immunotherapy X Li, S Ma, Y Deng, P Yi, J Yu Molecular cancer 21 (1), 76, 2022 | 108 | 2022 |
| An oncolytic virus expressing IL15/IL15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma R Ma, T Lu, Z Li, KY Teng, AG Mansour, M Yu, L Tian, B Xu, S Ma, ... Cancer research 81 (13), 3635-3648, 2021 | 108 | 2021 |
| Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding W Wang, H Sun, F Meng, S Ma, H Liu, Z Zhong Soft Matter 8 (14), 3949-3956, 2012 | 78 | 2012 |
| Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy S Ma, MA Caligiuri, J Yu Trends in immunology 43 (10), 833-847, 2022 | 66 | 2022 |
| IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects Y Liu, Y Wu, Y Wang, Y Cai, B Hu, G Bao, H Fang, L Zhao, S Ma, Q Cheng, ... Leukemia 29 (4), 939-946, 2015 | 56 | 2015 |
| Off-the-Shelf prostate stem cell antigen–directed chimeric antigen receptor natural killer cell therapy to treat pancreatic cancer KY Teng, AG Mansour, Z Zhu, Z Li, L Tian, S Ma, B Xu, T Lu, H Chen, ... Gastroenterology 162 (4), 1319-1333, 2022 | 55 | 2022 |
| YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells S Ma, B Sun, S Duan, J Han, T Barr, J Zhang, MB Bissonnette, ... Nature immunology 24 (2), 255-266, 2023 | 52 | 2023 |
| The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment Q Cheng, S Ma, D Lin, Y Mei, H Gong, L Lei, Y Chen, Y Zhao, B Hu, Y Wu, ... Cellular & Molecular Immunology 12 (6), 681-691, 2015 | 44 | 2015 |
| Combining DNA Vaccine and AIDA-1 in Attenuated Salmonella Activates Tumor-Specific CD4+ and CD8+ T-cell Responses Y Mei, L Zhao, Y Liu, H Gong, Y Song, L Lei, Y Zhu, Z Jin, S Ma, B Hu, ... Cancer immunology research 5 (6), 503-514, 2017 | 41 | 2017 |
| IL-1β and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administration Y Liang, S Ma, Y Zhang, Y Wang, Q Cheng, Y Wu, Y Jin, D Zheng, D Wu, ... The Journal of Immunology 192 (3), 1277-1285, 2014 | 37 | 2014 |
| Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19 T Lu, R Ma, W Dong, KY Teng, DS Kollath, Z Li, J Yi, C Bustillos, S Ma, ... Nature Communications 13 (1), 2576, 2022 | 28 | 2022 |
| ILC1s control leukemia stem cell fate and limit development of AML Z Li, R Ma, S Ma, L Tian, T Lu, J Zhang, BL Mundy-Bosse, B Zhang, ... Nature immunology 23 (5), 718-730, 2022 | 28 | 2022 |
| Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer L Song, S Ma, L Chen, L Miao, M Tao, H Liu Cancer science 110 (7), 2100-2109, 2019 | 28 | 2019 |
